AI-generated summary
The authors studied red light-emitting diode (LED) therapy on human skin cells in vitro and on full-thickness wounds in 50 Wistar rats. They report that LED increased keratinocyte viability, had minimal effect on cell migration, and was associated with changes in inflammation markers and antioxidant levels, including faster clinical healing by day 10. The findings are limited to a rat model and cell culture, and clinical trial confirmation is needed.
- Participants
- 50
- Who or what was studied
- Wistar rats with induced full-thickness dorsal wounds, and HaCaT human keratinocyte cells
- Limits stated in the abstract
- The study is limited to cell culture and an animal model, and the authors state that clinical trial confirmation is warranted.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Background
The clinical advantages of light-emitting diode (LED) therapy in skin healing and its underlying mechanism remain subjects of ongoing debate.
Objective
This study aims to explore the impact of LED therapy on normal skin keratinocytes (HaCaT) and in the repair of full-thickness dorsal wounds in Wistar rats.
Methods
HaCaT cell viability (SRB assay) and migration (scratch assay) were assessed under LED therapy, comparing stress conditions (2.5% FBS) with sham irradiation and optimal conditions (10% FBS). In vivo, 50 rats with induced wounds were divided into Sham and LED (daily treatment) groups. Euthanasia occurred at 3, 5, 10, 14, and 21 days for clinical, morphological, oxidative stress (MDA, SOD, and GSH), and cytokine analyses (IL-1β, IL-10, TNF-α).
Results
LED therapy significantly enhanced keratinocytes viability compared to sham irradiation, with minimal impact on cell migration. Clinical benefits were prominent on day 10, influencing inflammation progression and resolution on days 3 and 10. Re-epithelization remained unaffected. Reduced MDA and increased GSH levels were observed throughout, while SOD levels varied temporally. Notably, on day 10, LED significantly decreased IL-1β, IL-10, and TNF-α. STUDY LIMITATIONS: Although translational, clinical trial confirmation of observed benefits is warranted.
Conclusions
LED therapy expedites cutaneous healing in the experimental model, primarily modulating inflammation and enhancing antioxidant activity.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Light-emitting diode, Sham, Inflammation, Oxidative stress. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.